Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer episode artwork

EPISODE · Jul 1, 2025 · 57 MIN

Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer

from The Long Run with Luke Timmerman · host Timmerman Report

Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.

Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.

NOW PLAYING

Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer

0:00 57:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 57 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on July 1, 2025.

What is this episode about?

Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!